Project Number 5U01AG031294-04 Agency/Funding Organization NIA Funding Year 2011 View Full Project Details for HARNESSING GABA AND NO MIMETIC ACTIVITY FOR ALZHEIMER'S THERAPY Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator THATCHER, GREGORY R. J Principal Investigator First Name GREGORY R. J Principal Investigator Last Name THATCHER Awardee Organization UNIVERSITY OF ILLINOIS CHICAGO Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-05-148: Alzheimer's Disease Drug Development Program FY Overall Cost $346,128 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [AlzPED] A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease [AlzPED] Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
